This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
Sharps Compliance Inkomsten in het verleden
Verleden criteriumcontroles 1/6
Belangrijke informatie
77.0%
Groei van de winst
76.4%
Groei van de winst per aandeel
| Healthcare Groei van de industrie | 8.5% |
| Inkomstengroei | 16.1% |
| Rendement op eigen vermogen | 6.3% |
| Nettomarge | 5.8% |
| Laatste winstupdate | 31 Mar 2022 |
Recente prestatie-updates uit het verleden
Recent updates
Aurora Capital Partners affiliate to acquire Sharps Compliance for $8.75 per share
Jul 12We Like These Underlying Return On Capital Trends At Sharps Compliance (NASDAQ:SMED)
Jul 02
Is Sharps Compliance (NASDAQ:SMED) Using Too Much Debt?
Jun 13Sharps Compliance Corp.'s (NASDAQ:SMED) Shareholders Might Be Looking For Exit
May 25Here's Why I Think Sharps Compliance (NASDAQ:SMED) Might Deserve Your Attention Today
May 03Sharps Compliance: Update Prior To Important Earnings
Apr 26Sharps Compliance: An Operator In The Medical Waste Industry
Jan 04Is Sharps Compliance (NASDAQ:SMED) Using Too Much Debt?
Dec 06Time To Worry? Analysts Just Downgraded Their Sharps Compliance Corp. (NASDAQ:SMED) Outlook
Aug 20These 4 Measures Indicate That Sharps Compliance (NASDAQ:SMED) Is Using Debt Reasonably Well
Jun 18Sharps Compliance: Undervalued, Even If Growth Returns To Historical Levels
Jun 04With EPS Growth And More, Sharps Compliance (NASDAQ:SMED) Is Interesting
May 20Are Investors Undervaluing Sharps Compliance Corp. (NASDAQ:SMED) By 39%?
May 07Sharps Compliance EPS beats by $0.27, beats on revenue
Apr 28What Type Of Shareholders Own The Most Number of Sharps Compliance Corp. (NASDAQ:SMED) Shares?
Mar 15Has Sharps Compliance (NASDAQ:SMED) Got What It Takes To Become A Multi-Bagger?
Mar 01Upgrade: Analysts Just Made A Substantial Increase To Their Sharps Compliance Corp. (NASDAQ:SMED) Forecasts
Feb 02Earnings Beat: Sharps Compliance Corp. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Feb 01Is Sharps Compliance (NASDAQ:SMED) Weighed On By Its Debt Load?
Jan 26Sharps Compliance reports robust order activity
Jan 11Is There An Opportunity With Sharps Compliance Corp.'s (NASDAQ:SMED) 33% Undervaluation?
Jan 05
Don't Ignore The Fact That This Insider Just Sold Some Shares In Sharps Compliance Corp. (NASDAQ:SMED)
Dec 18Shareholders Are Thrilled That The Sharps Compliance (NASDAQ:SMED) Share Price Increased 117%
Dec 07Is Sharps Compliance Corp. (NASDAQ:SMED) Popular Amongst Insiders?
Nov 18Does Sharps Compliance (NASDAQ:SMED) Have A Healthy Balance Sheet?
Jul 24Does The Market Have A Low Tolerance For Sharps Compliance Corp.'s (NASDAQ:SMED) Mixed Fundamentals?
Jul 06Opbrengsten en kosten
Opbrengsten en kosten
Hoe Sharps Compliance geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 31 Mar 22 | 69 | 4 | 17 | 0 |
| 31 Dec 21 | 79 | 11 | 17 | 0 |
| 30 Sep 21 | 77 | 12 | 16 | 0 |
| 30 Jun 21 | 76 | 13 | 16 | 0 |
| 31 Mar 21 | 70 | 10 | 15 | 0 |
| 31 Dec 20 | 53 | 2 | 14 | 0 |
| 30 Sep 20 | 51 | 1 | 14 | 0 |
| 30 Jun 20 | 51 | 2 | 14 | 0 |
| 31 Mar 20 | 51 | 1 | 14 | 0 |
| 31 Dec 19 | 50 | 1 | 13 | 0 |
| 30 Sep 19 | 48 | 1 | 12 | 0 |
| 30 Jun 19 | 44 | 0 | 12 | 0 |
| 31 Mar 19 | 42 | 0 | 12 | 0 |
| 31 Dec 18 | 42 | 0 | 12 | 0 |
| 30 Sep 18 | 41 | -1 | 11 | 0 |
| 30 Jun 18 | 40 | -1 | 11 | 0 |
| 31 Mar 18 | 41 | 0 | 11 | 0 |
| 31 Dec 17 | 40 | 0 | 11 | 0 |
| 30 Sep 17 | 38 | 0 | 11 | 0 |
| 30 Jun 17 | 38 | -1 | 12 | 0 |
| 31 Mar 17 | 37 | -2 | 12 | 0 |
| 31 Dec 16 | 35 | -2 | 11 | 0 |
| 30 Sep 16 | 35 | -1 | 11 | 0 |
| 30 Jun 16 | 33 | 0 | 11 | 0 |
| 31 Mar 16 | 34 | 1 | 10 | 0 |
| 31 Dec 15 | 33 | 1 | 10 | 0 |
| 30 Sep 15 | 32 | 1 | 10 | 0 |
Kwaliteitswinsten: SMED has a large one-off gain of $2.2M impacting its March 31 2022 financial results.
Groeiende winstmarge: SMED's current net profit margins (5.8%) are lower than last year (14.2%).
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: SMED has become profitable over the past 5 years, growing earnings by 77% per year.
Versnelling van de groei: SMED's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Winst versus industrie: SMED had negative earnings growth (-59.4%) over the past year, making it difficult to compare to the Healthcare industry average (6.1%).
Rendement op eigen vermogen
Hoge ROE: SMED's Return on Equity (6.3%) is considered low.